Differential expression of JAK2 and Src kinase genes in response to hydroxyurea treatment in polycythemia vera and essential thrombocythemia
Enriqueta Albízua(Hospital Universitario HM Madrid), Joaquín Martínez‐López(Hospital Universitario 12 De Octubre), Inmaculada Rapado(Wellcome Sanger Institute), Eulàlia Puigdecanet(Universitat de Vic - Universitat Central de Catalunya), Beatriz Sánchez‐Espiridión(The University of Texas MD Anderson Cancer Center), Lourdes Florensa(Hospital Del Mar), Blanca Espinet(Hospital Del Mar), Rosa Ayala(Hospital Universitario 12 De Octubre), Miguel Gallardo(Spanish National Cancer Research Centre), Daniel Rueda(Research Institute Hospital 12 de Octubre), Ana Jiménez Ubieto(Hospital Universitario 12 De Octubre), Carles Besses(Hospital Del Mar), Santiago Barrio
Cited by 8
Related Papers
Somatic<i>SF3B1</i>Mutation in Myelodysplasia with Ring Sideroblasts
|New England Journal of Medicine|2011|1.2k
Teclistamab in Relapsed or Refractory Multiple Myeloma
|New England Journal of Medicine|2022|1.2k
Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma
|New England Journal of Medicine|2023|719
Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma
|New England Journal of Medicine|2021|532
Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial
|Nature Medicine|2021|523